Frontotemporal lobar degeneration.
Grossman M, Seeley WW, Boxer AL, Hillis AE, Knopman DS, Ljubenov PA, Miller B, Piguet O, Rademakers R, Whitwell JL, Zetterberg H, van Swieten JC.
Nat Rev Dis Primers. 2023 Aug 10;9(1):40. doi: 10.1038/s41572-023-00447-0.
Frontotemporal Lobar Degeneration.
Premi E, Padovani A, Borroni B.
Adv Exp Med Biol. 2012;724:114-27. doi: 10.1007/978-1-4614-0653-2_9.
HnRNP Pathologies in Frontotemporal Lobar Degeneration.
Jiang X, Gatt A, Lashley T.
Cells. 2023 Jun 15;12(12):1633. doi: 10.3390/cells12121633.
Neurotransmitter deficits from frontotemporal lobar degeneration.
Murley AG, Rowe JB.
Brain. 2018 May 1;141(5):1263-1285. doi: 10.1093/brain/awx327.
Immunological signatures in frontotemporal lobar degeneration.
Sirkis DW, Bonham LW, Karch CM, Yokoyama JS.
Curr Opin Neurol. 2019 Apr;32(2):272-278. doi: 10.1097/WCO.0000000000000665.
Imaging frontotemporal lobar degeneration.
Diehl-Schmid J, Onur OA, Kuhn J, Gruppe T, Drzezga A.
Curr Neurol Neurosci Rep. 2014 Oct;14(10):489. doi: 10.1007/s11910-014-0489-x.
Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.
Carlos AF, Josephs KA.
J Neurol. 2022 Aug;269(8):4030-4054. doi: 10.1007/s00415-022-11073-3. Epub 2022 Mar 23.
Review: Neuropathology of non-tau frontotemporal lobar degeneration.
Neumann M, Mackenzie IRA.
Neuropathol Appl Neurobiol. 2019 Feb;45(1):19-40. doi: 10.1111/nan.12526.
Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Mann DMA, Snowden JS.
Brain Pathol. 2017 Nov;27(6):723-736. doi: 10.1111/bpa.12486. Epub 2017 Mar 2.
Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.
Li YQ, Tan MS, Yu JT, Tan L.
Mol Neurobiol. 2016 Nov;53(9):6091-6105. doi: 10.1007/s12035-015-9507-5. Epub 2015 Nov 4.
